When comparing the broader topic of NSCLC to the more specific focus on EGFR exon 20 insertions, a substantial surge in ex20ins-related publications was noted after 2018, demonstrating the increasing attention this challenging mutation subset has received in recent years (Figure 5B). This evidence concerns the gene EGFR and non-small cell lung carcinoma.